Anti-inflammatory effect of MAPK phosphatase-1 local gene transfer in inflammatory bone loss

Gene Therapy

Volumn 18, Issue 4, 2011, Pages 344-353

  Yu, H ^a   Li, Q ^a   Herbert, B ^a,c   Zinna, R ^a   Martin, K ^a   Junior, C R ^a   Kirkwood, K L ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c School of Business   (United States)

Author keywords

cytokine; MKP 1; osteoclastogenesis; periodontal disease

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ADENOVIRUS VECTOR; CXCL1 CHEMOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; NUCLEAR FACTOR KAPPA B P105; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE P46; STRESS ACTIVATED PROTEIN KINASE P54; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; GENE TRANSFER; HUMAN; HUMAN CELL; IMMUNOREGULATION; INFLAMMATORY INFILTRATE; MACROPHAGE; MALE; MOUSE; NONHUMAN; OSTEITIS; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PERIODONTITIS; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; RAT; VIRAL GENE DELIVERY SYSTEM; WILD TYPE;

ALVEOLAR BONE LOSS; ANIMALS; DUAL SPECIFICITY PHOSPHATASE 1; GENE TRANSFER TECHNIQUES; IMMUNITY, INNATE; INFLAMMATION; MICE; MICE, KNOCKOUT; OSTEOCLASTS; PHOSPHORYLATION; RATS;

ADENOVIRIDAE; BACTERIA (MICROORGANISMS); MUS; RATTUS;

EID: 79953774682     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2010.139     Document Type: Article

References (37)

1. Brown LJ, Loe H. Prevalence, extent, severity and progression of periodontal disease. Periodontol 2000 1993; 2: 57-71.
2. Pilot T, Miyazaki H. Periodontal conditions in Europe. J Clin Periodontol 1991; 18: 353-357.
3. Hall TJ, Chambers TJ. Molecular aspects of osteoclast function. Inflamm Res 1996; 45: 1-9. (Pubitemid 26032099)
4. Reddy SV. Regulatory mechanisms operative in osteoclasts. Crit Rev Eukaryot Gene Expr 2004; 14: 255-270. (Pubitemid 40221056)
5. Nair SP, Meghji S, Wilson M, Reddi K, White P, Henderson B. Bacterially induced bone destruction: mechanisms and misconceptions. Infect Immun 1996; 64: 2371-2380. (Pubitemid 26226792)
6. Taubman MA, Valverde P, Han X, Kawai T. Immune response: the key to bone resorption in periodontal disease. J Periodontol 2005; 76: 2033-2041. (Pubitemid 41748950)
7. Mundy GR. Inflammatory mediators and the destruction of bone. J Periodontal Res 1991; 26: 213-217.
8. Hanazawa S, Amano S, Nakada K, Ohmori Y, Miyoshi T, Hirose K et al. Biological characterization of interleukin-1-like cytokine produced by cultured bone cells from newborn mouse calvaria. Calcif Tissue Int 1987; 41: 31-37.
9. Zou W, Bar-Shavit Z. Dual modulation of osteoclast differentiation by lipopoly-saccharide. J Bone Miner Res 2002; 17: 1211-1218. (Pubitemid 34680497)
10. Ishimi Y, Miyaura C, Jin CH, Akatsu T, Abe E, Nakamura Y et al. IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 1990; 145: 3297-3303.
11. Yang SH, Sharrocks AD, Whitmarsh AJ. Transcriptional regulation by the MAP kinase signaling cascades. Gene 2003; 320: 3-21. (Pubitemid 37352751)
12. Whitmarsh AJ. Regulation of gene transcription by mitogen-activated protein kinase signaling pathways. Biochim Biophys Acta 2007; 1773: 1285-1298. (Pubitemid 47125975)
13. Keyse SM. Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr Opin Cell Biol 2000; 12: 186-192. (Pubitemid 30142565)
14. Orcel P, Feuga M, Bielakoff J, De Vernejoul MC. Local bone injections of LPS and M-CSF increase bone resorption by different pathways in vivo in rats. Am J Physiol 1993; 264: E391-E397. (Pubitemid 23103951)
15. Nishida E, Hara Y, Kaneko T, Ikeda Y, Ukai T, Kato I. Bone resorption and local interleukin-1alpha and interleukin-1beta synthesis induced by Actinobacillus actino-mycetemcomitans and Porphyromonas gingivalis lipopolysaccharide. J Periodontal Res 2001; 36: 1-8. (Pubitemid 33644624)
16. Jiang Y, Mehta CK, Hsu TY, Alsulaimani FF. Bacteria induce osteoclastogenesis via an osteoblast-independent pathway. Infect Immun 2002; 70: 3143-3148. (Pubitemid 34564177)
17. Zhuang L, Jung JY, Wang EW, Houlihan P, Ramos L, Pashia M et al. Pseudomonas aeruginosa lipopolysaccharide induces osteoclastogenesis through a toll-like receptor 4 mediated pathway in vitro and in vivo. Laryngoscope 2007; 117: 841-847. (Pubitemid 46699355)
18. Ozaki Y, Ukai T, Yamaguchi M, Yokoyama M, Haro ER, Kaneko T et al. Locally administered T cells from mice immunized with lipopolysaccharide (LPS) accelerate LPS-induced bone resorption. Bone 2009; 44: 1169-1176.
19. Owens DM, Keyse SM. Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases. Oncogene 2007; 26: 3203-3213. (Pubitemid 46763015)
20. Zhao Q, Wang X, Nelin LD, Yao Y, Matta R, Manson ME et al. MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock. J Exp Med 2006; 203: 131-140. (Pubitemid 43139652)
21. Chi H, Barry SP, Roth RJ, Wu JJ, Jones EA, Bennett AM et al. Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc Natl Acad Sci USA 2006; 103: 2274-2279. (Pubitemid 43271660)
22. Salojin KV, Owusu IB, Millerchip KA, Potter M, Platt KA, Oravecz T. Essential role of MAPK phosphatase-1 in the negative control of innate immune responses. J Immunol 2006; 176: 1899-1907. (Pubitemid 43134335)
23. Sartori R, Li F, Kirkwood KL. MAP kinase phosphatase-1 protects against inflammatory bone loss. J Dent Res 2009; 88: 1125-1130.
24. Rogers JE, Li F, Coatney DD, Otremba J, Kriegl JM, Protter TA et al. A p38 mitogen-activated protein kinase inhibitor arrests active alveolar bone loss in a rat periodontitis model. J Periodontol 2007; 78: 1992-1998.
25. Wang X, Liu Y. Regulation of innate immune response by MAP kinase phosphatase-1. Cell Signal 2007; 19: 1372-1382. (Pubitemid 46830880)
26. Patil CS, Liu M, Zhao W, Coatney DD, Li F, VanTubergen EA et al. Targeting mRNA stability arrests inflammatory bone loss. Mol Ther 2008; 16: 1657-1664.
27. Kirkwood KL, Li F, Rogers JE, Otremba J, Coatney DD, Kreider JM et al. A p38alpha selective mitogen-activated protein kinase inhibitor prevents periodontal bone loss. J Pharmacol Exp Ther 2007; 320: 56-63. (Pubitemid 46025719)
28. Marie PJ. Human endosteal osteoblastic cells: relationship with bone formation. Calcif Tissue Int 1995; 56 (Suppl 1): S13-S16.
29. Miyamoto T, Suda T. Differentiation and function of osteoclasts. Keio J Med 2003; 52: 1-7. (Pubitemid 36460529)
30. Yavropoulou MP, Yovos JG. Osteoclastogenesis-current knowledge and future perspectives. J Musculoskelet Neuronal Interact 2008; 8: 204-216.
31. Teitelbaum SL. Osteoclasts: what do they do and how do they do it? Am J Pathol 2007; 170: 427-435. (Pubitemid 47339379)
32. Chen P, Li J, Barnes J, Kokkonen GC, Lee JC, Liu Y. Restraint of proinflammatory cytokine biosynthesis by mitogen-activated protein kinase phosphatase-1 in lipopoly-saccharide-stimulated macrophages. J Immunol 2002; 169: 6408-6416. (Pubitemid 36903490)
33. Kim MS, Magno CL, Day CJ, Morrison NA. Induction of chemokines and chemokine receptors CCR2b and CCR4 in authentic human osteoclasts differentiated with RANKL and osteoclast like cells differentiated by MCP-1 and RANTES. J Cell Biochem 2006; 97: 512-518. (Pubitemid 43265311)
34. Carlson J, Cui W, Zhang Q, Xu X, Mercan F, Bennett AM et al. Role of MKP-1 in osteoclasts and bone homeostasis. Am J Pathol 2009; 175: 1564-1573.
35. Li X, Udagawa N, Itoh K, Suda K, Murase Y, Nishihara T et al. p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function. Endocrinology 2002; 143: 3105-3113. (Pubitemid 34809883)
36. Zwerina J, Hayer S, Redlich K, Bobacz K, Kollias G, Smolen JS et al. Activation of p38 MAPK is a key step in tumor necrosis factor-mediated inflammatory bone destruction. Arthritis Rheum 2006; 54: 463-472. (Pubitemid 43228620)
37. Wilson ME, Hamilton RG. Immunoglobulin G subclass response of localized juvenile periodontitis patients to Actinobacillus actinomycetemcomitans Y4 lipopolysaccharide. Infect Immun 1992; 60: 1806-1812.